Loading...
Endothelin receptor antagonists in sickle cell disease: a promising new therapeutic approach
Sickle cell disease (SCD) is a genetic hematologic disorder that is characterized by a variety of potentially life threatening acute and chronic complications. Currently, hydroxyurea is the only clinically approved pharmacological therapy for the treatment of SCD, and the continued prevalence of sev...
Saved in:
| Published in: | Life Sci |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992628/ https://ncbi.nlm.nih.gov/pubmed/27049871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2016.04.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|